Michigan State University Leadership
Samuel L. Stanley Jr., M.D.
Samuel L. Stanley Jr., M.D., was selected by the Michigan State University Board of Trustees as MSU’s 21st president, effective Aug. 1, 2019. Since his arrival at MSU, Dr. Stanley has moved decisively to ensure the university is a safe, respectful, and welcoming place for all. Student success and well-being and continuing to grow MSU’s extraordinary regional and global impact are his continuing top priorities.
Stanley has launched a comprehensive strategic planning process for the university, created a diversity, equity and inclusion planning committee and commissioned a feasibility study for a multicultural center. He appointed two expert presidential advisers who are directing the development and implementation of an action plan for the university to become a leader in preventing relationship violence and sexual misconduct.
Stanley has overseen several changes in the institution’s administration, organization, and programs to improve services, operations, and accountability. These include reorganizing oversight of the university’s three medical colleges and its clinical services into a health sciences entity. He seeks to continue to expand the university’s research portfolio, totaling $725 million in 2019 expenditures. A researcher, patent holder and former technology transfer executive, Stanley supports academic and industry collaborations to leverage both their economic impact and the potentially enormous contributions they can make to society.
Born in Seattle, Stanley earned a Bachelor of Arts in biological sciences (Phi Beta Kappa) from the University of Chicago. After earning his medical degree from Harvard Medical School, he completed resident-physician training at Massachusetts General Hospital and then went to Washington University in St. Louis for a School of Medicine fellowship in infectious diseases. There, he became a professor in the departments of medicine and molecular microbiology, recognizing the collaborative nature of his research. A distinguished biomedical researcher, Stanley was one of the nation’s top recipients of support from the National Institutes of Health for his research focusing on enhanced defense against emerging infectious diseases. He is an expert in the biological mechanisms that cells employ when responding to infectious agents.
Prior to becoming MSU’s president, Stanley served as president of Stony Brook University on Long Island in New York. At Stony Brook, he focused on improving campus diversity and student success and elevated the university’s research profile by supporting a new institute for artificial intelligence. He chaired the board of Brookhaven Science Associates, which manages Brookhaven National Laboratory on behalf of the U.S. Department of Energy.
Stanley has served as chair of the National Science Advisory Board for Biosecurity, which advises the U.S. government on issues related to the communication, dissemination, and performance of sensitive biological research. He was a member of the National Advisory Allergy and Infectious Diseases Council at the NIH and a member of the NIH director’s Blue Ribbon Panel on the National Emerging Infectious Diseases Laboratories. He also served as an ambassador for the Paul G. Rogers Society for Global Health Research and has received an Honorary Doctorate in Science from Konkuk University in South Korea. He is a member of the Board of Directors of the Association of American Universities and has served on the NCAA Board of Directors and NCAA Board of Governors.
Norman J. Beauchamp Jr., M.D., MHS
Dr. Norman J. Beauchamp Jr. was promoted to MSU executive vice president for health sciences in October 2019, after serving as associate provost and assistant vice president for health affairs for MSU since February 2018, and dean of the MSU College of Human Medicine since October 2016.
Before coming to MSU, Beauchamp held academic medicine leadership positions at Johns Hopkins University and the University of Washington, where he served as president of the prestigious UW clinical practice of 1,600 physicians employed by the university.
A nationally renowned neurointerventional radiologist whose discoveries have advanced the treatment of stroke, Beauchamp received his bachelor’s degree from Michigan State University, his medical degree from the MSU College of Human Medicine and his master’s degree in health science from Johns Hopkins School of Public Health. He completed his residency and two fellowships at Johns Hopkins School of Medicine before joining the faculty in 1996.
An influential scientist and national leader in the radiology community, Beauchamp has received numerous awards for his research and has published more than 100 peer-reviewed papers. His research focuses on developing advanced MRI imaging techniques to extend the treatment window for acute ischemic stroke and identifying risk predictors for stroke and dementia.
Beauchamp is chair of the International Outreach Committee of the American Roentgen Ray Society and on the board of directors of the Society of Chairs of Academic Radiology Departments. He previously served as the president of both of those organizations. He was also chairperson of the Radiology Research Alliance, the Coalition for Bioimaging Research and the American Radiology Education Committee.
Andrea Amalfitano, DO, Ph.D.
Dr. Andrea Amalfitano has served as dean of the MSU College of Osteopathic Medicine since 2018.
Amalfitano has also served as director of MSU’s Clinical and Translational Sciences Institute and the title of Osteopathic Heritage Foundation Endowed Professor of Pediatrics, Microbiology and Molecular Genetics since 2005.
Prior to his work at MSU, he served as an associate professor at Duke University in the Departments of Pediatrics and Pathology, Molecular Genetics and Microbiology.
His research focuses on determining the feasibility of cutting-edge therapeutics, including gene transfer, to treat both acquired and genetic diseases and translating that knowledge into the clinical realm. His scholarly efforts in both clinical medicine and applied genetics have led to the development of innovative treatments for infants, children and adults affected by a variety of diseases, including lethal muscular dystrophies, infectious diseases such as COVID-19, cancer and autoimmune disorders.
Amalfitano has been published in hundreds of publications, with millions of dollars in research funding, including National Institutes of Health, to help advance his work.
Amalfitano earned a bachelor degree and doctorate in microbiology, both from Michigan State University. He earned his Doctor of Osteopathic Medicine, or DO, medical degree from MSU College of Osteopathic Medicine’s DO/Ph.D. dual-degree program.
Seth Ciabotti is the chief executive officer of MSU Health Care. Known for his leadership to rebuild, revitalize and optimize organizational structures to improve patient access and satisfaction, he has 20 years of success in the health care industry. His broad health care experience covers many facets, both from the payer and care delivery aspect including insurance, inpatient hospital service lines and academic faculty practices.
Ciabotti recently held the position as vice president of ambulatory operations for Mount Sinai Health System in New York City. Under his leadership, the faculty group increased market share growth through acquisitions, standardization, joint ventures and strategic business planning. The faculty practice growth for the system is comprised of eight hospitals, 2,700 employed physicians with 4 million annual visits and $2.9 billion in annual revenue.
Ciabotti brought several new initiatives to Mount Sinai Health System during his tenure, including a Patient Access Center, EPIC Cadence/Resolute implementation with self-check-in kiosks and robotic processing automation. The Patient Access Center won two awards from the Patient Access Collaborative, a prestigious invite-only consortium of 80-plus academic medical centers.
Ciabotti also has held positions as chief administrative officer/executive director of Prime Care Physicians, PLLC and St. Peter’s Health Partners, a practice administrator for a surgery group, practice supervisor for a spine and rehabilitative center, care coordinator for counseling services, administrative coordinator and claims coordinator for Blue Cross Blue Shield.
He holds a master’s degree in health administration from Hofstra University, a bachelor’s degree from University at Albany and an administrative fellowship from Kings County Hospital Center in Brooklyn.
Randolph F.R. Rasch, Ph.D., RN, FNP, FAANP
Dr. Randolph F. R. Rasch is dean and professor of the MSU College of Nursing. He has over 25 years of experience teaching in BSN, MSN, DNP and Ph.D. programs in nursing.
Before he was appointed dean, Rasch served as chair of the Department of Community Practice Nursing in the School of Nursing at the University of North Carolina at Greensboro, and as the director of two well-known family nurse practitioner programs in the Vanderbilt University School of Nursing and the School of Nursing at the University of North Carolina at Chapel Hill.
Rasch was the first statewide director of nursing services/programs director in the Tennessee Department of Correction, where he provided leadership and direction for nursing services and assisted the director of health services with the overall development, management and operation of TDOC Health Services. As part of a three-member management team, Rasch was responsible for designing and implementing a system of health care for the TDOC, and as programs director, leading the development and facilitating the implementation of the Quality Assurance Program for Health Services.
Rasch’s clinical experiences as a registered nurse include charge nurse on a surgical unit in a community hospital and public health nurse and PHN Team Leader and home health nurse in a county health department. As an FNP, he has provided care in a prison system; a corporate health care center; and a nurse-managed clinic recognized as a clinical agency by the North Carolina Board of Nursing.
A fellow in the American Academy of Nursing, a fellow in the American Association of Nurse Practitioners and a distinguished scholar and fellow in the National Academies of Practice, Rasch holds the distinction of being the first African American male graduate of the nursing program at Andrews University, and the first African American male Master’s-prepared FNP. He is the first African American male to hold a Ph.D. in nursing and was the first African American male public health nurse in the state of Michigan.
Aron Sousa, M.D., FACP
Dr. Aron Sousa was appointed interim dean of the MSU College of Human Medicine in October 2019. He previously served as interim dean in 2015 and 2016, before the appointment of Norman J. Beauchamp Jr. as dean.
In his previous role, Sousa served as senior associate dean for academic affairs at the college, a post he’s held since 2006. He was responsible for the educational programs of the college across the seven community campuses in the state. During that time, he managed the doubling of the college’s class size and converting its two-year, 60 student Grand Rapids campus into a four-year, 350 student campus. He also led the creation of a pair of new, two-year clinical campuses in Traverse City and Midland.
The majority of Sousa’s work is in medical education and curriculum. He led the design of the college’s new and highly successful Shared Discovery Curriculum, which is characterized by robust clinical experiences in each year of medical school, promotion based on progress testing and content organized by chief complaint rather than organ system or discipline. Sousa leads the college’s accreditation activity and regularly serves as a site team member for the Liaison Committee on Medical Education. As the leader of the college’s $30 million expansion in Flint, Sousa was the principal investigator on the C.S. Mott grants that led to the college establishing the College of Human Medicine building and the creation of the Division of Public Health in Flint.
Sousa is a practicing general internist. He received his bachelor’s degree in chemistry and his medical degree from Indiana University School of Medicine. He then served as both a resident and chief resident in internal medicine and completed a Primary Care Fellowship at Michigan State University.